BTC Health, an SJE Group investment, has appointed Mr Bruce Hewett as a non-executive Director and Board member.
Bruce graduated as a pharmacist and has had over 30 years experience in all aspects of the pharmaceutical industry. He has held a number of senior leadership roles, initially with Janssen-Cilag and Faulding DBL and more recently with the UK based speciality pharmaceutical and services company, Clinigen plc. Bruce brings a strong track record of founding and building businesses in the Australian and New Zealand pharmaceutical industries and much of this success has been underpinned by his extensive network of industry contacts around the world.
The SJE Group congratulates Chairman Richard Treagus and Bruce Hewett on this appointment.